Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer

Clinical trial NCT04428671 · RECRUITING

Trial details

NCT number: NCT04428671
Sponsor: Emory University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Skin Squamous Cell Carcinoma Recurrent Skin Squamous Cell Carcinoma

Start date: 2020-05-15
Primary completion: 2030-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.